ATYR Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline Without Revenue
60 Degrees Pharmaceuticals Inc SXTP Q1 2026 Earnings EPS Misses Estimates No Revenue Yet
ALSN Q1 2026 Earnings Strong Earnings Beat Drives Positive Stock Response
JACK Q1 2026 Earnings EPS Slightly Misses Estimates but Stock Surges Over 8
Passage Bio Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Sentiment
Federated Hermes Inc FHI Q1 2026 Earnings Solid EPS Beat Drives Positive Market Response